Sudden death in adult congenital heart disease: risk stratification in 2014

Edward P Walsh1

  • 1Cardiac Electrophysiology Division, Boston Children's Hospital, Boston, Massachusetts, and Harvard Medical School, Boston, Massachusetts.

Heart Rhythm
|July 22, 2014
PubMed

Insights

Identifying adults with congenital heart disease at high risk for arrhythmias and sudden death is challenging. This review updates risk stratification and management strategies for these complex cardiac conditions.

Area of Science:

  • Cardiology
  • Adult Congenital Heart Disease
  • Cardiac Electrophysiology

Background:

  • Adult congenital heart disease (ACHD) survivors face significant risks of arrhythmias and sudden cardiac death.
  • Accurate risk stratification in ACHD is complicated by small patient populations, low event rates, and evolving surgical techniques.
  • Historically, single-center studies lacked the statistical power to establish robust risk criteria.

Purpose of the Study:

  • To provide an updated review of risk stratification for major congenital cardiac lesions in adults.
  • To outline current recommendations for surveillance and management of ACHD patients at risk for adverse cardiac events.

Main Methods:

  • Review of current literature and collaborative project data on risk stratification in ACHD.
  • Analysis of evolving surgical approaches and their impact on long-term outcomes.
  • Synthesis of evidence to inform surveillance and management guidelines.

Main Results:

  • Larger collaborative studies are now enabling the development of more objective risk assessment criteria.
  • Significant advancements in understanding arrhythmia mechanisms and sudden death risk in ACHD.
  • Emerging data supports tailored surveillance and management based on specific cardiac malformations.

Conclusions:

  • Risk stratification in ACHD is improving due to larger datasets and collaborative research.
  • Updated guidelines are crucial for optimizing surveillance and management to reduce adverse events.
  • Continued research is needed to further refine risk prediction and improve outcomes for ACHD patients.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
801
Cardiopulmonary Resuscitation I: Adult01:21

Cardiopulmonary Resuscitation I: Adult

Cardiopulmonary resuscitation, or CPR, is a life-saving emergency procedure performed when a person's heart has stopped beating or they are no longer breathing. The foundation of CPR is Basic Life Support (BLS), which focuses on the early recognition of cardiac arrest, the immediate start of high-quality chest compressions, and the timely use of an automated external defibrillator (AED).Assessing Responsiveness and Checking the Carotid PulseWhen approaching an unresponsive person, first ensure...
1.2K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
861
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
616
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
813
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
2.0K